Comparison of Patient Satisfaction and Audiological Performance Between Neuro 1 and Neuro 2 Speech Processors
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sensorineural Hearing Loss
- Sponsor
- Oticon Medical
- Enrollment
- 98
- Locations
- 9
- Primary Endpoint
- Satisfaction questionnaire
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The present study aims to evaluate patient satisfaction and audiological performance with their current cochlear implant speech processor, the Neuro 1, and to compare it with the satisfaction and performance obtained with the new speech processor, the Neuro 2.
Detailed Description
Nowadays, cochlear implants (CI) are successfully used to rehabilitate severe to profound sensorineural hearing loss. Oticon Medical recently developed a new cochlear implant system, including a new implantable internal part (Neuro Zti) and a new speech processor (Neuro 1). This new speech processor automatically detects and adapts to the sound environment, increasing the ease of listening in all situations. A second version of this speech processor has very recently been developed, called the Neuro 2. The Neuro 1 and 2 share the same signal processing characteristics and the "sound" delivered to the patient is similar. However, the Neuro 2 offers better ergonomics (smaller size and weight, rechargeable batteries...). Some improvements available on the Neuro 2 may be particularly interesting for children. The aim of the present study is twofold: 1. Compare the satisfaction of adult and pediatric users for the speech processor Neuro 1 with their satisfaction for the Neuro 2, and 2. Show that audiological outcomes are at least as good for the Neuro 2 than for the Neuro 1. The participants come at the hospital for three visits. The Neuro 1 is evaluated during the first visit (V1). Evaluation of the Neuro 2 takes place during the second (V2, 15 days after V1) and the third (V3, 3 months after V2).
Investigators
Eligibility Criteria
Inclusion Criteria
- •informed consent
- •Native French speaker or fluent French speaker
- •Patient already fitted with one or two speech processor Neuro 1 for at least 5 months
Exclusion Criteria
- •vulnerable patients, at the exception of children (pregnant women, persons under guardianship)
- •No Social security affiliation
- •non-compliant patient
Outcomes
Primary Outcomes
Satisfaction questionnaire
Time Frame: 15 minutes
The listener has to rate his appreciation of the Neuro 1 and Neuro 2 device and the sound quality on 7 points scale. The outcome measure corresponds to averaged score. The questionnaire has been developed by Oticon Medical to investigate satisfaction patient for their current and future speech processors. This questionnaire is not validated in the literature.
Secondary Outcomes
- Speech comprehension in quiet(15 mins)
- Speech comprehension in Noise(15 mins)
- French Quick Sin(5 mins)